Karen Read’s civil lawsuit has been moved from state court to federal court following a request by the attorney representing key witnesses at her murder trials who she has accused of framing her in ...

Dua Lipa in a lace top, hit like a spark from backstage in Mexico City on Instagram. The pop star slips into a mauve pink, string-tied lace cami with scandalous cutouts. Her caption nods to CDMX, ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Christine is a freelance writer for Collider with two decades of experience covering all types of TV shows and movies spanning every genre. With a particular affinity for dramas, true crime, sitcoms, ...

“I think we will be leaning into what’s going on now. The current state of affairs is daunting; the world is upside down and how do we navigate through this world of half-truths? What is real?

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Abbott said Thursday it would buy Exact Sciences, the maker of tests ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...

The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. The KYY K3 (not to be confused with the K3-1 or K3-2) is a ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics company. Three cancer test launches, multiple study readouts and one $23 ...

Us Weekly has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! These clogs embody Aniston’s effortless, California-cool aesthetic in the best ...